In our investigation of the XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms and their role in cancer development, we noted no association with the XRCC2 polymorphism, while the XRCC3 polymorphism exhibited a negative association, indicating a protective effect against GI cancer risk in the studied population. Here, XRCC2 is linked to cancer.